Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Anquil
2. Benperidol Neuraxpharm
3. Benperidol-neuraxpharm
4. Benperidolneuraxpharm
5. Frenactil
6. Glianimon
1. 2062-84-2
2. Anquil
3. Frenactil
4. Glianimon
5. Frenactyl
6. Concilium
7. Mcn-jr-4584
8. Benzoperidol
9. Benzperidol
10. Glianimon Mite
11. R-4584
12. Benzeridol
13. R 4584
14. Cb 8089
15. 8089 C. B.
16. 2h-benzimidazol-2-one, 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl]-1,3-dihydro-
17. Nsc-170982
18. 2h-benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl)-1,3-dihydro-
19. 8089 C.b.
20. 1-(1-(3-(p-fluorobenzoyl)propyl)-4-piperidyl)-2-benzimidazolinone
21. 3-[1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl]-1h-benzimidazol-2-one
22. Nsc170982
23. 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl}-1h-benzo[d]imidazol-2(3h)-one
24. 97o6x78c53
25. Ncgc00016602-01
26. Cas-2062-84-2
27. 2-benzimidazolinone, 1-[1-[3-(p-fluorobenzoyl)propyl]-4-piperidyl]-
28. Dsstox_cid_25364
29. Dsstox_rid_80827
30. Dsstox_gsid_45364
31. 983-42-6
32. Anquil (van)
33. Benperidolo [dcit]
34. Benperidolo
35. Benperidolum
36. 1-{1-(3-(p-fluorobenzoyl)propyl)-4-piperidyl}-2-benzimidazolinone
37. 2-benzimidazolinone, 1-(1-(3-(p-fluorobenzoyl)propyl)-4-piperidyl)-
38. 3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl]-1h-benzimidazol-2-one
39. Benperidolum [inn-latin]
40. 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)piperidin-4-yl)-1,3-dihydro-2h-benzo[d]imidazol-2-one
41. 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)piperidin-4-yl)-1h-benzo[d]imidazol-2(3h)-one
42. 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl]-1,3-dihydro-2h-benzimidazol-2-one
43. Benperidol [usan:inn:ban]
44. Mcn-jr 4584
45. Einecs 218-172-2
46. Nsc 170982
47. Brn 0900981
48. Benquil
49. 1-1-(3-(p-fluorobenzoyl)propyl)-4-piperidyl-2-benzimidazolinone
50. 1-1-[3-(p-fluorobenzoyl)propyl]-4-piperidyl-2-benzimidazolinone
51. Unii-97o6x78c53
52. 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-one
53. Anquil Hydrochloride
54. Prestwick_778
55. Anquil (tn)
56. Frenactyl Hydrochloride
57. Benperidol [mi]
58. Benzperidol Hydrochloride
59. Benperidol [inn]
60. 4'-fluor-4-(4-(2-oxo-1-benzimidazolinyl)piperidino)butyrophenon
61. Benperidol (usan/inn)
62. Prestwick0_000484
63. Prestwick1_000484
64. Prestwick2_000484
65. Prestwick3_000484
66. Benperidol [usan]
67. Benperidol [mart.]
68. Benperidol [who-dd]
69. Bspbio_000347
70. 5-24-02-00375 (beilstein Handbook Reference)
71. Mls002153837
72. Schembl122650
73. Spbio_002268
74. Bpbio1_000383
75. Chembl297302
76. Gtpl9215
77. Dtxsid7045364
78. Bdbm81492
79. Chebi:93403
80. Benperidol [ep Monograph]
81. 2-benzimidazolinone, Hydrochloride
82. Hms1569b09
83. Hms2096b09
84. Hms2235h20
85. Hms3374b03
86. Hms3713b09
87. Zinc9232411
88. Tox21_110517
89. Bdbm50183266
90. Nsc_16363
91. Nsc169873
92. Pdsp1_000835
93. Pdsp2_000822
94. 3-[1-[4-(4-fluorophenyl)-4-oxo-butyl]-4-piperidyl]-1h-benzimidazol-2-one
95. Akos016339645
96. Tox21_110517_1
97. Ccg-220484
98. Db12867
99. Ks-1335
100. Nsc-169873
101. Ncgc00016602-02
102. Ncgc00016602-04
103. Ac-12200
104. Smr001233200
105. Cas_2062-84-2
106. Db-045313
107. Hy-121276
108. 2-benzimidazolinone, Hydrochloridemonohydrate
109. Cs-0081352
110. Ft-0634013
111. Wln: T56 Bmvnj D- Dt6ntj A3vr Df
112. D02627
113. 062b842
114. A814756
115. L000947
116. Q424412
117. Sr-01000841254
118. 2h-benzimidazol-2-one,3-dihydro-, Monohydrochloride
119. Sr-01000841254-2
120. Brd-k79425933-001-03-6
121. {1-1-[3-(p-fluorobenzoyl)propyl]-4-piperidyl-2-benzimidazolinone}
122. 1-[1-[3-(p-fluorbenzoyl)propyl]-4-piperidyl]-2-benzimidazolinon
123. 2-benzimidazolinone, {1-[1-[3-(p-fluorobenzoyl)propyl]-4-piperidyl]-}
124. Gamma-[4-(2-oxo-1-benzimidazolinyl)-piperidino]-p-fluorobutyrophenone
125. 1-[1-[4-(4-fluorophenyl)-4-oxo-butyl]-4-piperidyl]-3h-benzoimidazol-2-one
126. 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl}-1h-benzo[d] Imidazol-2(3h)-one
127. 2-benzimidazolinone, {1-[1-[3-(p-fluorobenzoyl)propyl]-4-piperidyl]-,} Hydrochloridemonohydrate
128. 2h-benzimidazol-2-one, {1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl]-1,3-dihydro-}
| Molecular Weight | 381.4 g/mol |
|---|---|
| Molecular Formula | C22H24FN3O2 |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 6 |
| Exact Mass | 381.18525518 g/mol |
| Monoisotopic Mass | 381.18525518 g/mol |
| Topological Polar Surface Area | 52.6 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 556 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
N05AD07
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
N - Nervous system
N05 - Psycholeptics
N05A - Antipsychotics
N05AD - Butyrophenone derivatives
N05AD07 - Benperidol
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Benperidol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Benperidol, including repackagers and relabelers. The FDA regulates Benperidol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Benperidol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Benperidol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Benperidol supplier is an individual or a company that provides Benperidol active pharmaceutical ingredient (API) or Benperidol finished formulations upon request. The Benperidol suppliers may include Benperidol API manufacturers, exporters, distributors and traders.
click here to find a list of Benperidol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Benperidol CEP of the European Pharmacopoeia monograph is often referred to as a Benperidol Certificate of Suitability (COS). The purpose of a Benperidol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Benperidol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Benperidol to their clients by showing that a Benperidol CEP has been issued for it. The manufacturer submits a Benperidol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Benperidol CEP holder for the record. Additionally, the data presented in the Benperidol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Benperidol DMF.
A Benperidol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Benperidol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Benperidol suppliers with CEP (COS) on PharmaCompass.
Benperidol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Benperidol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Benperidol GMP manufacturer or Benperidol GMP API supplier for your needs.
A Benperidol CoA (Certificate of Analysis) is a formal document that attests to Benperidol's compliance with Benperidol specifications and serves as a tool for batch-level quality control.
Benperidol CoA mostly includes findings from lab analyses of a specific batch. For each Benperidol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Benperidol may be tested according to a variety of international standards, such as European Pharmacopoeia (Benperidol EP), Benperidol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Benperidol USP).
LOOKING FOR A SUPPLIER?
